
PMID- 29080264
OWN - NLM
STAT- Publisher
LR  - 20171124
IS  - 1747-0285 (Electronic)
IS  - 1747-0277 (Linking)
DP  - 2017 Oct 27
TI  - Derivatizations of Sgc8-c aptamer to prepare metallic radiopharmaceuticals as
      imaging diagnostic agents: Syntheses, isolations, and physicochemical
      characterizations.
LID - 10.1111/cbdd.13135 [doi]
AB  - Aptamers, oligonucleotides with the capability to bind to a target through
      non-covalent bonds with high affinity and specificity, have a great number of
      advantages as scaffold to prepare molecular imaging agents. In this sense, we
      have performed post-SELEX modifications of a truncated aptamer, Sgc8-c, which
      bind to protein tyrosine kinase 7 to obtain a specific molecular targeting probe 
      for in vivo diagnosis and in vivo therapy. Herein, we describe the synthetic
      efforts to prepare conjugates between Sgc8-c and different metallic ions chelator
      moieties in short times, high purities, and adequate yields. The selected
      chelator moieties, derived from
      1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid,
      2-benzyl-1,4,7-triazacyclononane-1,4,7-triacetic acid, and 6-hydrazinonicotinic
      acid, were covalently attached at the 5'-aptamer position yielding the expected
      products which were stable in aqueous solution up to 75 degrees C and in typical 
      aptamer storage conditions at least for 30 days.
CI  - (c) 2017 John Wiley & Sons A/S.
FAU - Sicco, Estefania
AU  - Sicco E
AD  - Area de Radiofarmacia, Facultad de Ciencias, Centro de Investigaciones Nucleares,
      Universidad de la Republica, Montevideo, Uruguay.
AD  - Departamento de Desarrollo Biotecnologico, Facultad de Medicina, Instituto de
      Higiene, Universidad de la Republica, Montevideo, Uruguay.
FAU - Baez, Jessica
AU  - Baez J
AD  - Area de Radiofarmacia, Facultad de Ciencias, Centro de Investigaciones Nucleares,
      Universidad de la Republica, Montevideo, Uruguay.
AD  - Facultad de Quimica, Centro de Evaluacion de Biodisponibilidad y Bioequivalencia 
      de Medicamentos, Universidad de la Republica, Montevideo, Uruguay.
FAU - Margenat, Jimena
AU  - Margenat J
AD  - Area de Radiofarmacia, Facultad de Ciencias, Centro de Investigaciones Nucleares,
      Universidad de la Republica, Montevideo, Uruguay.
FAU - Garcia, Fernanda
AU  - Garcia F
AD  - Area de Radiofarmacia, Facultad de Ciencias, Centro de Investigaciones Nucleares,
      Universidad de la Republica, Montevideo, Uruguay.
FAU - Ibarra, Manuel
AU  - Ibarra M
AD  - Facultad de Quimica, Centro de Evaluacion de Biodisponibilidad y Bioequivalencia 
      de Medicamentos, Universidad de la Republica, Montevideo, Uruguay.
FAU - Cabral, Pablo
AU  - Cabral P
AD  - Area de Radiofarmacia, Facultad de Ciencias, Centro de Investigaciones Nucleares,
      Universidad de la Republica, Montevideo, Uruguay.
FAU - Moreno, Maria
AU  - Moreno M
AD  - Departamento de Desarrollo Biotecnologico, Facultad de Medicina, Instituto de
      Higiene, Universidad de la Republica, Montevideo, Uruguay.
FAU - Cerecetto, Hugo
AU  - Cerecetto H
AUID- ORCID: http://orcid.org/0000-0003-1256-3786
AD  - Area de Radiofarmacia, Facultad de Ciencias, Centro de Investigaciones Nucleares,
      Universidad de la Republica, Montevideo, Uruguay.
FAU - Calzada, Victoria
AU  - Calzada V
AD  - Area de Radiofarmacia, Facultad de Ciencias, Centro de Investigaciones Nucleares,
      Universidad de la Republica, Montevideo, Uruguay.
LA  - eng
PT  - Journal Article
DEP - 20171027
PL  - England
TA  - Chem Biol Drug Des
JT  - Chemical biology & drug design
JID - 101262549
OTO - NOTNLM
OT  - DOTA
OT  - HYNIC
OT  - NOTA
OT  - aptamer
OT  - post-SELEX modifications
OT  - radiopharmaceutical
EDAT- 2017/10/29 06:00
MHDA- 2017/10/29 06:00
CRDT- 2017/10/29 06:00
PHST- 2017/05/22 00:00 [received]
PHST- 2017/07/09 00:00 [revised]
PHST- 2017/10/04 00:00 [accepted]
PHST- 2017/10/29 06:00 [pubmed]
PHST- 2017/10/29 06:00 [medline]
PHST- 2017/10/29 06:00 [entrez]
AID - 10.1111/cbdd.13135 [doi]
PST - aheadofprint
SO  - Chem Biol Drug Des. 2017 Oct 27. doi: 10.1111/cbdd.13135.
